Skip to main content

ERShares

Filter Media

Recent Media

XOVR pours $30m into prediction market firm Kalshi

ERShares, adviser to the Nasdaq-listed ERShares Private-Public Crossover ETF (XOVR), has committed $30m to Kalshi,...

READ ARTICLE

Joel Shulman on Bloomberg TV: XOVR, SpaceX Exposure & the Private-Public Crossover ETF

Joel Shulman, Founder & CIO of ERShares, joined Bloomberg TV to discuss SpaceX, Elon Musk,...

After SpaceX, ETF XOVR taps into prediction market demand with $30 million Kalshi investment

ERShares’ Private-Public Crossover ETF (Ticker: XOVR) has made a $30 million investment in Kalshi, the...

READ ARTICLE

EXCLUSIVE: SpaceX Sparked New ETF Race for Private Market Access; ‘Passive Funds Are Buying at $1.75T What We Bought Years Earlier,’ Says ERShares CIO

Space Exploration Technologies Corp’s (NASDAQ:SPCX) record-breaking rise from IPO to the Nasdaq-100 in just 15...

READ ARTICLE

XOVR ETF Reports 27.45%* Q2 Return as SpaceX Strategy Delivers

READ ARTICLE

Eva Ados: XOVR Shareholder Protection Plan Around the SpaceX IPO

Eva Ados discusses XOVR's Shareholder Protection Plan around the SpaceX IPO in an interview from...

Eva Ados Called Astera Labs ($ALAB): The AI Infrastructure Layer

This May 11th interview highlights the bigger AI infrastructure thesis Eva Ados discussed with Charles...

Eva Ados on CNBC: Nvidia, AI Productivity & the Revenue Per Employee Metric Investors Are Missing

Eva Ados, COO and Chief Investment Strategist at ERShares, joined CNBC Morning Call to discuss...

Eva Ados on Astera Labs

In this May 1st interview, Eva Ados discussed my “Triple A” AI basket: Astera Labs,...

Eva Ados on SpaceX IPO Day

In my latest interview, I explained XOVR's 3-step Shareholder Protection Plan around the SpaceX IPO:...

Past performance is no guarantee of future results. Please refer to the following disclosures:

The hyperlinks and website references on this page may forward you to third-party websites. All descriptions of, reference to, or links to other products, publications, or services do not constitute an endorsement by ERShares unless expressly stated by ERShares. The information, products, and sites accessible through this page have not necessarily been reviewed by ERShares and are provided or maintained by the third parties over whom ERShares does not exercise control. ERShares does not claim any responsibility for the content, accuracy, or quality of the information, products, and/or services provided by or advertised on these third-party websites. ERShares reserves the right to terminate any hyperlink at any time without notice.

Get access to fund materials

Stay up-to-date with market trends

To invest/know more about our products